Atara Biotherapeutics Analyst Ratings
BenzingaApr 1 10:53 ET
Stifel Adjusts Atara Biotherapeutics Price Target to $2.30 From $4.80, Maintains Hold Rating
MT NewswiresApr 1 09:27 ET
Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA) and Embecta Corporation (EMBC)
TipRanksApr 1 07:30 ET
Analysts Offer Insights on Healthcare Companies: Affimed (AFMD) and Atara Biotherapeutics (ATRA)
TipRanksMar 31 22:20 ET
Atara Biotherapeutics (ATRA) Gets a Buy From TD Cowen
TipRanksMar 28 16:06 ET
Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA), Moderna (MRNA) and Madrigal Pharmaceuticals (MDGL)
TipRanksMar 1 08:00 ET
Atara Biotherapeutics (ATRA) Gets a Hold From H.C. Wainwright
TipRanksDec 21, 2023 06:27 ET
Atara Biotherapeutics Analyst Ratings
BenzingaNov 10, 2023 10:53 ET
Goldman Sachs Sticks to Its Sell Rating for Atara Biotherapeutics (ATRA)
TipRanksNov 9, 2023 08:29 ET
Atara Biotherapeutics Analyst Ratings
BenzingaNov 9, 2023 07:11 ET
Mizuho Securities Downgrades Atara Biotherapeutics to Neutral From Buy, Slashes Price Target to $1 From $31
MT NewswiresNov 9, 2023 06:57 ET
Analysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH), Atara Biotherapeutics (ATRA) and Tempest Therapeutics (TPST)
TipRanksNov 9, 2023 06:54 ET
H.C. Wainwright Downgrades Atara Biotherapeutics (ATRA) to a Hold
TipRanksNov 9, 2023 06:53 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Vir Biotechnology (VIR) and Atara Biotherapeutics (ATRA)
TipRanksNov 6, 2023 05:11 ET
HC Wainwright & Co. Reiterates Buy on Atara Biotherapeutics, Maintains $28 Price Target
BenzingaSep 26, 2023 06:35 ET
Atara Biotherapeutics Analyst Ratings
BenzingaSep 26, 2023 06:34 ET
Analysts Offer Insights on Healthcare Companies: Aptose Biosciences (APTO), Harmony Biosciences Holdings (HRMY) and Atara Biotherapeutics (ATRA)
TipRanksSep 21, 2023 07:32 ET
Atara Biotherapeutics Analyst Ratings
BenzingaAug 21, 2023 07:42 ET
EF Hutton Reiterates Buy on Atara Biotherapeutics, Maintains $25 Price Target
BenzingaAug 9, 2023 07:26 ET
Atara Biotherapeutics Analyst Ratings
BenzingaAug 9, 2023 07:26 ET
No Data
No Data